Pfizer Global Supply

Pfizer Global Supply operated 42 manufacturing sites with a diverse ecosystem of systems, datasets, and differing process standards inherited from 30+ legacy pharmaceutical companies. Insights were difficult to extract and transforming the operational technology layer was a complex multi-year challenge.

PGS developed a digital transformation strategy starting from a 'blank slate' approach, building a data-driven insight engine across its global operations. The program aligned digital capabilities with a lean manufacturing initiative to create standard work codified through digital tools.

At one manufacturing site alone, the digital transformation program enabled the manufacture of 3 million additional doses of one product above the planned quantity for 2019. Documented improvements were achieved in cycle time, manufacturing throughput, yield, and right-first-time quality.

• Pharmaceutical digital transformation requires long-term planning (3+ years) before full benefits materialize
• Aligning digital capabilities with lean manufacturing initiatives creates multiplicative value
• Executive sponsorship and willingness to experiment are critical success factors for large-scale OT digital transformation